ClinicalTrials.Veeva

Menu

Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting

N

National University of Malaysia (UKM)

Status

Enrolling

Conditions

Fatty Liver Disease

Treatments

Behavioral: Intermittent Fasting

Study type

Interventional

Funder types

Other

Identifiers

NCT05880316
UKM/PPI/111/8/JEP-2023-276

Details and patient eligibility

About

This study consists of 2 parts:

Part 1: a cross-sectional study, looking at the prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) among nurses in Hospital Canselor Tuanku Muhriz (HCTM).

Part 2: a randomized controlled trial of intermittent fasting with MAFLD subjects.

Full description

The investigators aim to screen at least 350 participants for fibroscan-detected fatty liver. Baseline anthropometric data will be taken. Questionnaires on dietary habits - Foof Frequency Questionnaire (FFQ) and exercise habits - International Physical Activity Questionnaire (IPAQ) will be done.

Approximately 100 participants who have fatty liver from Part 1 study, will be enrolled and randomized into Part 2. The intervention group will undergo intermittent fasting (3 fasting day:4 non-fasting days) while the control group will continue the usual standard care, for 8 weeks.

Measurements pre- and post-intervention include Fibroscan measurement, blood LiverFASt, anthropometric data, and exercise habit (IPAQ).

Enrollment

100 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • nurses at HCTM, 18 years and above

Exclusion criteria

  • pregnancy
  • previous bariatric surgery
  • liver cirrhosis
  • liver cancer
  • steatogenic drugs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Intermittent Fasting Group
Experimental group
Description:
IF regime: 3 fasting day: 4 non-fasting day. On fasting day - allows to eat restricted calorie diet (up to 70% total daily calorie intake) for 8 hours.
Treatment:
Behavioral: Intermittent Fasting
Non-Fasting Group
No Intervention group
Description:
Usual care. Not allowed to fast

Trial contacts and locations

1

Loading...

Central trial contact

Khairul Najmi M Nawawi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems